Delivery Order SPE2DB22D1106-SPE2DB25FEQQ7
Award Date
5/29/25
Potential Completion Date
5/30/25
Potential Value
$10K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, to supply Dupixent 300 mg/2 ml pens. The contract has a ceiling value of $9,393.78 and runs through September 20, 2024. The contract is a firm fixed-price delivery order, with no set-aside designation. As a large Indefinite Delivery Contract (IDC) holder with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025,...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Dupixent 300 mg/2 ml pens, a medication used to treat certain medical conditions. The contract has a ceiling value of $75,545.53 and is a firm fixed-price, non-set-aside contract with a performance period ending on May 2, 2025. AmerisourceBergen Drug Corp holds a significant...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Dupixent 300 mg/2 ml pens, a prescription medication, with a ceiling value of $21,614.82 and a period of performance through April 2025. The contract is not set aside and is a firm-fixed-price delivery order. AmerisourceBergen holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Dupixent 300 mg/2 ml pens. The contract has a ceiling value of $110,301.03 and is a firm fixed price, non-set-aside delivery order with a performance period ending on May 1, 2025. AmerisourceBergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a comprehensive...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Dupixent 300 mg/2 ml pens, a specialty pharmaceutical product, to support military healthcare programs. The contract has a ceiling value of $10,669.97 and runs through November 12, 2024. The contract is a firm fixed-price delivery order with no set-aside designation, indicating...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Dupixent 300 mg/2 ml pens, a medication used to treat certain medical conditions. The contract has a ceiling value of $16,943.62 and is a firm fixed-price, non-set-aside contract with a performance period ending on May 6, 2025. AmerisourceBergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery...
This is a firm-fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $13,870.34, is for the supply of Dupixent 200 mg/1.14 ml pens, a medication used to treat certain medical conditions. The contract has an ultimate completion date of April 29, 2025 and is not a set-aside. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Dupixent 300 mg/2 ml pens, a pharmaceutical product, with a ceiling value of $12,634.70. The contract is a delivery order, with a firm fixed price pricing type, and has an ultimate completion date of April 16, 2025. The contract is not set aside and is open to competition....
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Dupixent 300 mg/2 ml pens, a medication used to treat certain medical conditions. The contract has a ceiling value of $14,676.26 and a performance period ending on April 28, 2025. This contract is not set aside for any specific business type. AmerisourceBergen Drug Corp holds a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Dupixent 300 mg/2 ml pens, with a ceiling value of $104,031.09 and a performance period through April 29, 2025. The contract is a firm fixed-price, non-set-aside arrangement. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support...